We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
A summary of recent letters and notifications sent to healthcare professionals about medicines and medical devices.
Product defect recall alert for Purevax® RCP FeLV lyophilisate and solvent for suspension for injection Vm 04491/5054, Purevax® RCP lyophilisate solvent for suspension for injection Vm 04491/5053, Eurican Herpes 205 Powder and Solvent for Emulsion for Injection Vm 04491/5008 by...
Correspondence regarding the anticipated acquisition of TMG by RB Investco Ltd.
medac GmbH (t/a medac Pharma LLP) is recalling the product for the batch specified in this notification due to particles detected during long-term stability tests.
Explains testing from 1 April 2024 onwards and sets out the purpose of ongoing testing, who will be eligible to access testing and when tests should be used.
A new pathway supporting innovative approaches to the safe, timely and efficient development of medicines to improve patient access.
How to notify the MHRA of your intention to carry out a clinical investigation for medical devices.
Orifarm UK has informed the MHRA of an error with the Patient Information Leaflet (PIL) packaged within the parallel import packs of the specific batches of Concerta XL 18mg and 36mg prolonged release tablets mentioned in this notification.
How we evaluated pre-exposure prophylactic (preventative) treatments for COVID-19.
Check the tariff classification for surface-active preparation for washing the skin and the hair (gel 2-in-1).
Product Recall for Vincenza Jewellery Pave Zircon Initial Cord Bracelet presenting a serious chemical risk.
Information relating to rare side effects after vaccination.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The government's summary about the use of iron milk caseinate in total diet replacement for weight control and in food for special medical purposes.
Recommendations for a temporary class drug order on a number of methylphenidate-based novel psychoactive substances.
Atnahs Pharma UK Ltd has informed the MHRA that the batches of Clobazam Atnahs 5mg/5ml and 10mg/5ml Oral Suspension listed in this notification do not contain the most up to date safety information.
Get help to classify herbal medicines, vitamins, food preparations, supplements and tonics for import and export.
Find out about the long-term effects some people can have after having COVID-19.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. We’ll send you a link to a feedback form. It will take only 2 minutes to fill in. Don’t worry we won’t send you spam or share your email address with anyone.